Seeing Is Believing
RCKT is currently covered by 12 analysts with an average price target of $53.49. This is a potential upside of $26.24 (96.29%) from yesterday's end of day stock price of $27.25.
Rocket Pharmaceuticals's activity chart (see below) currently has 31 price targets and 67 ratings on display. The stock rating distribution of RCKT is 97.67% BUY and 2.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 24.23% with an average time for these price targets to be met of 151.38 days.
Highest price target for RCKT is $61, Lowest price target is $35, average price target is $53.49.
Most recent stock forecast was given by COLIN BRISTOW from UBS on 01-Mar-2024. First documented stock forecast 27-Nov-2018.
Currently out of the existing stock ratings of RCKT, 42 are a BUY (97.67%), 1 are a HOLD (2.33%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
54
$26.75 (98.17%)
62
27 days ago
0/2 (0%)
$23.47 (76.88%)
Buy
50
$22.75 (83.49%)
9
1 months 1 days ago
2/5 (40%)
$19.26 (62.65%)
88
Buy
53
$25.75 (94.50%)
53
1 months 15 days ago
0/9 (0%)
$24.03 (82.95%)
Buy
50
$22.75 (83.49%)
47
4 months 20 days ago
0/3 (0%)
$30.43 (155.49%)
Buy
48
$20.75 (76.15%)
48
6 months 15 days ago
0/4 (0%)
$26.77 (126.10%)
What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?
Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?
Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?